Although their findings showed that the expression of cCD155 was a poor prognostic factor, there have been no reports on the association between cCD155 expression and clinicopathological findings, nor have there been reports on the correlation between soluble CD155 levels in the blood and cCD155 expression levels in tumor cells. This evidence concerns the gene PVR and neoplasm.